Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
New research presented at the Endocrine Societys 2025 Annual Meeting (ENDO 2025) has revealed that tirzepatidea medication originally developed for weight loss and type 2 diabetesmay offer surprising benefits for men suffering from both obesity and functional hypogonadism (low testosterone due to metabolic causes)
The choice between medications often depends on individual response and side effect profiles
Eur Rev Med Pharmacol Sci (2019) 23(5):1899906
Composition of the endothelial glycocalyx and its relation to its thickness and diffusion of small solutes
US$ 23.47
US$ 26.43
US$ 25.98
US$ 27.78
US$ 26.93
US$ 26.27
US$ 22.86
